Description

Telmisartan, a potent angiotensin II receptor blocker (ARB), is used in research on blood pressure regulation, cardiovascular health, and renal protection. It selectively inhibits AT? receptors, inducing vasodilation and reduced systemic pressure. Telmisartan also exhibits partial PPAR?? activation, supporting metabolic and endothelial research.

Produced by Jiangsu Yabang Epsom Pharmaceutical Co., Ltd., with NMPA approval H20041522, this product offers high?purity 40?mg tablets for laboratory and wholesale distribution.

?? Strictly for research—no clinical or therapeutic use.

Telmisartan Tablets Product Specifications

Telmisartan Tablets Mechanism of Action

Telmisartan blocks angiotensin II from binding AT? receptors, preventing vasoconstriction and lowering blood pressure. Additionally, it acts as a partial PPAR?? agonist, supporting studies on metabolism and endothelial function .

Telmisartan Tablets Research Applications

• Hypertension models and blood pressure modulation

• Cardiovascular protection & vascular function assays

• Renal injury and nephropathy studies

• Metabolic research involving PPAR?? pathways

• Combination therapy screening (e.g., with diuretics or antihypertensives)

Safety & Handling

• Use gloves, goggles, lab coat in handling

• Known side effects (from clinical data): dizziness, hypotension, hyperkalemia, rare impact on kidney/liver

• Discontinue research use in pregnancy models (fetal risk)

• Follow institutional disposal and biohazard guidelines

Core Keywords

Telmisartan tablets 40?mg, CAS 144701?48?4, ARB hypertension research, Yabang Hengbei telmisartan, lab telmisartan supply, PPAR?? telmisartan study, cardiovascular research tablets, wholesale telmisartan

Research Use Disclaimer

This product is intended for laboratory and preclinical research only. It is not approved for clinical, diagnostic, therapeutic, or veterinary use. Misuse may pose legal and health risks—use only in compliance with institutional protocols.